Haemophilus Influenzae (Hib) Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Persistency Study After Hib-CRM197 or Hib-TT Vaccines in Chinese Children
Conditions: Haemophilus Influenzae Type b Invasive Disease; Gram-negative Invasive InfectionsInterventions: Biological: Hib-CRM197 in V37_07E1; Biological: Hib-TT in V37_07E1 studySponsors: Novartis; Novartis VaccinesNot yet recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 14, 2014 Category: Research Source Type: clinical trials

Persistency Study After Hib-CRM197 or Hib-TT Vaccines in Chinese Children
Conditions: Haemophilus Influenzae Type b Invasive Disease; Gram-negative Invasive InfectionsInterventions: Biological: Hib-CRM197 in V37_07E1; Biological: Hib-TT in V37_07E1 studySponsors: Novartis; Novartis VaccinesCompleted - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2014 Category: Research Source Type: clinical trials

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants
Conditions: Poliomyelitis; Diphtheria; Haemophilus Influenzae Type b; Tetanus; Acellular Pertussis; Hepatitis BInterventions: Biological: Infanrix hexa; Biological: Pediarix; Biological: ActHIB; Biological: Pentacel; Biological: Engerix-B; Biological: Infanrix; Biological: Hiberix; Biological: Prevnar13; Biological: RotarixSponsor: GlaxoSmithKlineActive, not recruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2014 Category: Research Source Type: clinical trials

DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants
Conditions: Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b Infection; Poliomyelitis; Hepatitis BInterventions: Biological: DTaP-IPV-Hep B-PRP~T combined vaccine; Biological: DTaP-IPV//PRP~T and Hepatitis B vaccineSponsors: Sanofi Pasteur, a Sanofi Company; SanofiRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2014 Category: Research Source Type: clinical trials

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants
Conditions: Poliomyelitis; Diphtheria; Haemophilus Influenzae Type b; Tetanus; Acellular Pertussis; Hepatitis BInterventions: Biological: Infanrix hexa; Biological: Pediarix; Biological: ActHIB; Biological: Pentacel; Biological: Engerix-B; Biological: Infanrix; Biological: Hiberix; Biological: Prevnar13; Biological: RotarixSponsor: GlaxoSmithKlineRecruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2014 Category: Research Source Type: clinical trials